Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction

Gastric cancer patients with severe liver dysfunction secondary to hepatic metastases have limited treatment options. Most cytotoxic drugs have a narrow therapeutic index. Although both capecitabine and oxaliplatin have been well tolerated as single agents for patients with severe hepatic dysfunctio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hwang, Seung Jae, Park, Jong Won, Lee, Sehe Dong, Kim, Gyong Jung, Sin, Cheol Ho, Nam, Seung-Hyun, Kim, Bong-Seog
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association of Internal Medicine 2006
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891032/
https://ncbi.nlm.nih.gov/pubmed/17249509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.4.252
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak